A detailed history of Penserra Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Penserra Capital Management LLC holds 141 shares of ABT stock, worth $16,341. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141
Previous 141 -0.0%
Holding current value
$16,341
Previous $15,000 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $864,003 - $954,253
-7,889 Reduced 98.24%
141 $16,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $152,060 - $186,134
-1,686 Reduced 17.35%
8,030 $883,000
Q3 2023

Nov 15, 2023

SELL
$95.53 - $114.62 $147,975 - $177,546
-1,549 Reduced 13.75%
9,716 $940,000
Q2 2023

Aug 11, 2023

BUY
$100.78 - $112.29 $1.13 Million - $1.25 Million
11,171 Added 11884.04%
11,265 $1.23 Million
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $2.71 Million - $3.19 Million
-27,972 Reduced 99.67%
94 $9,000
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $2.67 Million - $3.13 Million
28,066 New
28,066 $3.08 Million
Q2 2020

Aug 14, 2020

SELL
$76.57 - $98.0 $1.05 Million - $1.34 Million
-13,703 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $206,049 - $301,300
3,280 Added 31.47%
13,703 $1.28 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $258,140 - $287,371
3,288 Added 46.08%
10,423 $907,000
Q3 2019

Nov 15, 2019

BUY
$81.84 - $88.74 $294,378 - $319,197
3,597 Added 101.67%
7,135 $596,000
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $381,672 - $445,145
-5,237 Reduced 59.68%
3,538 $297,000
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $2.66 Million - $3.21 Million
-40,113 Reduced 82.05%
8,775 $701,000
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $2.72 Million - $3.08 Million
41,463 Added 558.42%
48,888 $3.54 Million
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $451,514 - $544,698
7,425 New
7,425 $544,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.